Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 4/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 2/20 | 0.36 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.36 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7996644 | 0.86 | ERN1 (0.38) | ERN1CYP2A6PTGDR2CA1CA2 | |
| SCHEMBL15430114 | 0.83 | ERN1 (0.59) | ERN1CYP2A6PTGDR2PTPN1CA1 | |
| SCHEMBL20607770 | 0.77 | TYR (0.46) | ERN1TYRTRIM24TRIM33 | |
| SCHEMBL3784501 | 0.77 | KDM4E (0.50) | CYP2A6TSHRALDH1A1TYRTRIM24 | |
| SCHEMBL29951345 | 0.77 | SRC (0.46) | ERN1CYP2A6CA2TSHRALDH1A1 | |
| SCHEMBL14797280 | 0.77 | SRC (0.46) | ERN1CYP2A6CA2TSHRALDH1A1 | |
| SCHEMBL380410 | 0.75 | TDP1 (0.57) | ERN1PTPN1ALDH1A1TYRTRIM24 | |
| SCHEMBL31502405 | 0.75 | KDM4E (0.43) | ERN1PTPN1ALDH1A1TYRTRIM24 | |
| SCHEMBL14697059 | 0.75 | KDM4E (0.43) | ERN1PTPN1ALDH1A1TYRTRIM24 | |
| SCHEMBL8715929 | 0.75 | TSHR (0.46) | ERN1CYP2A6CA1CA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680612-A1 | CHEMICAL COMPOUNDS | AN2 Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192309-A1 | CHEMICAL COMPOUNDS | REACTIVE BIOSCIENCES, INC. (US) | 2024-09-19 | — | — | WO | disclosed |